Both in Biotechnology
Pelthos Therapeutics vs INmune Bio
Over the past year PTHS returned −72.5% and INMB returned −30.8%; their daily moves had a correlation of 0.14.
PTHS −72.5% INMB −30.8%Growth of $1, one year, split-adjusted
| Metric | PTHS | INMB |
|---|---|---|
| Price | $9.55 | $1.19 |
| Market cap | $37.5M | $36.8M |
| Today | −5.91% | −10.53% |
| 1 month | −54.5% | −36.0% |
| 6 months | −61.8% | −16.8% |
| Year to date | −69.2% | −23.7% |
| 1 year | — | −30.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | 76.9% | — |
| Net margin | −150.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | -$45.7M | $18.4M |
| Dividend yield | — | — |
| Volatility (60d) | 140.9% | 68.6% |
| Short % of float | 8.6% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).